Assessing whether Monash IVF Group Limited (ASX: MVF) is undervalued or overvalued involves analyzing its price-to-earnings multiple, discounted cash flow models, and projected future profitability relative to the broader Australian healthcare sector. Value-oriented investors examine whether current share prices accurately reflect the enterprise's long-term growth prospects in reproductive medicine, international clinic expansion, and steady operational earnings performance against prevailing market sentiment and macroeconomic headwinds.